- Home
- OMI vs RAPT Comparison
OMI vs RAPT Comparison
Compare OMI & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMI
- RAPT
- Stock Information
- Founded
- OMI 1882
- RAPT 2015
- Country
- OMI United States
- RAPT United States
- Employees
- OMI N/A
- RAPT N/A
- Industry
- OMI Medical Specialities
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- OMI Health Care
- RAPT Health Care
- Exchange
- OMI Nasdaq
- RAPT Nasdaq
- Market Cap
- OMI 415.6M
- RAPT 498.4M
- IPO Year
- OMI N/A
- RAPT 2019
- Fundamental
- Price
- OMI $3.35
- RAPT $28.27
- Analyst Decision
- OMI Hold
- RAPT Strong Buy
- Analyst Count
- OMI 7
- RAPT 9
- Target Price
- OMI $7.54
- RAPT $57.00
- AVG Volume (30 Days)
- OMI 1.9M
- RAPT 701.5K
- Earning Date
- OMI 10-30-2025
- RAPT 11-12-2025
- Dividend Yield
- OMI N/A
- RAPT N/A
- EPS Growth
- OMI N/A
- RAPT N/A
- EPS
- OMI N/A
- RAPT N/A
- Revenue
- OMI $10,768,859,000.00
- RAPT N/A
- Revenue This Year
- OMI N/A
- RAPT N/A
- Revenue Next Year
- OMI N/A
- RAPT N/A
- P/E Ratio
- OMI N/A
- RAPT N/A
- Revenue Growth
- OMI 132.03
- RAPT N/A
- 52 Week Low
- OMI $3.27
- RAPT $5.67
- 52 Week High
- OMI $15.54
- RAPT $42.39
- Technical
- Relative Strength Index (RSI)
- OMI 26.05
- RAPT 52.74
- Support Level
- OMI $3.27
- RAPT $29.09
- Resistance Level
- OMI $5.60
- RAPT $31.64
- Average True Range (ATR)
- OMI 0.38
- RAPT 3.06
- MACD
- OMI -0.18
- RAPT -0.65
- Stochastic Oscillator
- OMI 3.43
- RAPT 16.40
About OMI Owens & Minor Inc.
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.